Shionogi

This large, completed study tested a new COVID-19 vaccine called S-268019-b from Shionogi. Nearly 10,000 people who had not been infected or vaccinated before participated. The main goal was to see if the vaccine could prevent people from getting sick with COVID-19 compared to a …

This study tested an oral medication called S-217622 against a placebo (inactive pill) in over 2000 adults with mild-to-moderate COVID-19 who were not in the hospital. The goal was to see if the medication could help people feel better faster and reduce the amount of virus in the…

This study tested an experimental drug called S-892216 to see if it could reduce the amount of COVID-19 virus in people recently infected. It involved 282 adults with mild-to-moderate symptoms who started treatment within 3 days of feeling sick. The main goal was to measure how m…

This study aimed to understand how the antibiotic cefiderocol works in the bodies of very young infants (from birth to under 3 months old) who were hospitalized with serious bacterial infections. Researchers measured the drug's levels in the blood and checked for side effects in …

This study tested the safety and how the body processes the antibiotic cefiderocol in hospitalized children with serious bacterial infections. It involved 53 children, from 3 months to under 18 years old, who had infections like pneumonia, sepsis, or urinary tract infections. Res…

This early-stage study aimed to understand how a drug called BPN14770 behaves in people with different levels of liver damage. Researchers gave a single dose to 32 people, including healthy volunteers and those with mild, moderate, or severe liver impairment. They measured how mu…

This early study aimed to understand how a drug called BPN14770 is processed by the body in people with severe kidney impairment. It compared 14 participants—some with healthy kidneys and some with severe kidney problems—to see how the drug's levels in the blood differed between …

This was an early-stage study to check the safety of a new drug called S-740792 in healthy people. Researchers gave different doses to 99 volunteers to see how their bodies handled the drug and if it caused any side effects. The main goal was to gather basic safety information to…